CardioSignal presented data at ESC 2024 annual meeting on atrial fibrillation detection reliability among people suspected of various heart conditions
Posted:
CardioSignal’s CEO, co-founder, and cardiologist Juuso Blomster presented the results in the session: Transforming population health through mobile technology at the European Society of Cardiology (ESC) annual meeting that was being held in London on 30 August - 2 September.
A wave of British scientific breakthroughs is poised to transform how prostate cancer is found and treated.
Prostate cancer is the most common cancer in men across the UK, and the second most common cause of cancer deaths after lung cancer. …
Free live virtual Learna Open Day for healthcare professionals considering postgraduate study. See how online study works, view the platform live, and submit questions. Wed 11 Feb, 13:00 GMT.
Read more and register here.
Attendees
Sponsors and Exhibitors
Contact us